Transmitral E/A ratio decreases in association with abdominal fat accumulation in patients with impaired glucose tolerance or mild diabetes without left ventricular hypertrophy

Heart and Vessels

Volumn 25, Issue 1, 2010, Pages 41-44

  Wada, Hiromichi ^a   Shinjo, Daisuke ^a   Kameda, Sachika ^a   Ono, Koh ^a   Satoh, Noriko ^a   Morimoto, Tatsuya ^a   Osakada, Genta ^a   Nakano, Tameo ^a   Fujita, Masatoshi ^b   Shimatsu, Akira ^a   Hasegawa, Koji ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Abdominal obesity; Diastolic abnormality; Echocardiography; Impaired glucose tolerance

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ABDOMINAL FAT; ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DECELERATION; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE BLOOD FLOW; HEART RATE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PRIORITY JOURNAL; SEX DIFFERENCE; ABDOMINAL OBESITY; ASIAN; BLOOD; CROSS-SECTIONAL STUDY; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; GLUCOSE INTOLERANCE; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; JAPAN; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; HYPOGLYCEMIC AGENTS; JAPAN; MALE; MIDDLE AGED; MITRAL VALVE; OBESITY, ABDOMINAL; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; WAIST CIRCUMFERENCE;

EID: 77951790754     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1165-y     Document Type: Article

References (33)

1. Soläng L, Malmberg K, Rydén L (1999) Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J 20:789-795
2. Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29-34
3. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR (1999) Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146 (Pubitemid 29416243)
4. Rubier S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595-602
5. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194-202
6. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK (2003) Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42:328-335 (Pubitemid 36851426)
7. Cosson S, Kevorkian JP (2003) Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes Metab 29:455-466
8. Bell DS (2003) Diabetic cardiomyopathy. Diabetes Care 26:2949-2951
9. Fujita M, Asanuma H, Kim J, Liao Y, Hirata A, Tsukamoto O, Minamino T, Hori M, Goto M, Node K, Kitakaze M (2007) Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction. Int J Cardiol 118: 76-80 (Pubitemid 46517699)
10. Bertoni AG, Goff DC Jr, D'Agostino RB Jr, Liu K, Hundley WG, Lima JA, Polak JF, Saad MF, Szklo M, Tracy RP, Siscovick DS (2006) Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 29:588-594 (Pubitemid 44115359)
11. Valle R, Bagolin E, Canali C, Giovinazzo P, Barro S, Aspromonte N, Carbonieri E, Milani L (2006) The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur J Echocardiogr 7:40-44 (Pubitemid 43103039)
12. Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, Marwick TH (2005) Screening for heart disease in diabetic subjects. Am Heart J 149:349-354 (Pubitemid 40348547)
13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458 (Pubitemid 16119719)
14. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H (1996) A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 19:1138-1141
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083 (Pubitemid 9091990)
16. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 1440-1463.
18. Ruddy TD, Shumak SL, Liu PP, Barnie A, Seawright SJ, McLaughlin PR, Zinman B (1988) The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitus. J Clin Endocrinol Metab 66:113-118 (Pubitemid 18027738)
19. Raev DC (1994) Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 17:633-639
20. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105:1387-1393 (Pubitemid 34260433)
21. Spirito P, Maron BJ (1988) Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function. Br Heart J 59:672-679
22. Gardin JM, Arnold AM, Bild DE, Smith VE, Lima JA, Klopfenstein HS, Kitzman DW (1998) Left ventricular diastolic filling in the elderly: the cardiovascular health study. Am J Cardiol 82: 345-351 (Pubitemid 28364252)
23. Ohno M, Cheng CP, Little WC (1994) Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 89:2241-2250 (Pubitemid 24142804)
24. Kitzman DW, Sheikh KH, Beere PA, Philips JL, Higginbotham MB (1991) Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol 18:1243-1250
25. Lakatta EG, Sollott SJ (2002) Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol A Mol Integr Physiol 132:699-721
26. Lopaschuk GD, Folmes CD, Stanley WC (2007) Cardiac energy metabolism in obesity. Circ Res 101:335-347
27. Oliver MF, Opie LH (1994) Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343:155-158 (Pubitemid 24028646)
28. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T (1992) Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41:1422-1428
29. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H (2000) Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 101:899-907 (Pubitemid 30117886)
30. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET, Fabsitz RR, Howard BV, Devereux RB (2002) Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 105:1928-1933 (Pubitemid 34437620)
31. Rodriguez L, Garcia M, Ares M, Griffin BP, Nakatani S, Thomas JD (1996) Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J 131:982-987 (Pubitemid 26135764)
32. Cheung EW, Lam WW, Cheung SC, Cheung YF.Functional implications of the right ventricular myocardial performance index in patients after surgical repair of tetralogy of Fallot (2008) Heart Vessels 23:112-117
33. Senju N, Ikeda S, Koga S, Miyahara Y, Tsukasaki K, Tomonaga M, Kohno S (2007) The echocardiographic Tei-index reflects early myocardial damage induced by anthracyclines in patients with hematological malignancies. Heart Vessels 22:393-397 (Pubitemid 350201435)